Investors with more than $13 trillion in combined assets are calling on global policymakers to set a science-based target to curb the spread of superbugs, drawing inspiration from a similar blueprint used to tackle planet-warming emissions.
Legal & General Investment Management and Aviva Investors are among 80 institutions that have signed an open statement seeking an international framework and scientific panel to address the challenge of bacterial resistance around the globe.
